Teratogenicity is the ability of a substance or agent to cause malformations in a developing embryo or fetus. A teratogen is an agent that can cause such malformations, which can range from a minor physical abnormality to a major birth defect. Examples of teratogens include alcohol, certain drugs, heavy metals, radiation, and certain infections. Teratogenicity is caused by exposure to a teratogen during the prenatal period, which begins at conception and ends at birth. During this period, the developing embryo or fetus is particularly sensitive to any exposure to teratogens, because the cells and organs of the body are rapidly dividing and forming. If a teratogen is present during this period, it can damage the developing embryo or fetus, leading to malformations or birth defects. The exact mechanism by which teratogens cause such malformations is still not fully understood. It is thought to involve a combination of direct toxicity to the developing embryo or fetus, as well as disruption of normal development processes. In some cases, the teratogen may interfere with the expression of genes that are important for normal development. Teratogenicity is a significant cause of birth defects in humans, and it is important to be aware of potential teratogens in order to reduce the risk of malformations. In many cases, avoiding exposure to known teratogens is the best way to reduce the risk of teratogenicity.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia